Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial. [electronic resource]
Producer: 20160317Description: 899-906 p. digitalISSN:- 1464-5491
- Aged
- Canada -- epidemiology
- Cardiovascular Diseases -- complications
- Combined Modality Therapy -- economics
- Cost-Benefit Analysis
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Angiopathies -- economics
- Diabetic Cardiomyopathies -- economics
- Drug Monitoring -- economics
- Female
- Follow-Up Studies
- Health Care Costs
- Humans
- Male
- Middle Aged
- Patient Acceptance of Health Care
- Patient Care Team -- economics
- Pharmacists -- economics
- Primary Health Care
- Risk Factors
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.